Molecular Diagnostics Market to Achieve Significant Growth

Global Molecular Diagnostics Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

According to a new report published by Allied Market Research, titled, "Molecular Diagnostics Market by Type (Instruments, Reagents, and Software & Services), Technology (PCR, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, and Others), and End User (Hospitals, Reference Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023"

The global market was valued at $5,962 million in 2016, and is expected to garner $10,557 million by 2023, registering a CAGR of 9.1% during the forecast period 2017-2023.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/2170

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Abbott Laboratories, Inc., BioMrieux SA, Becton, Dickinson and Company, Cepheid (subsidiary of Danaher Corporation) (Denmark), Grifols, Hologic Corporation, Novartis AG, Qiagen N.V., Siemens Healthcare GmbH, and Roche Diagnostics.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2170

Key Benefits
o The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
o Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
o It offers a quantitative analysis from to enable the stakeholders to capitalize on the prevailing market opportunities.
o Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
o Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Molecular Diagnostics Market Key Segments
By Product
o Instruments
o Reagents
o Software & Services

By Technology
o Polymerase Chain Reactions (PCR)
o Hybridization
o DNA Sequencing
o Microarray
o Isothermal Nucleic Acid Amplification Technology (INAAT)
o Others (Electrophoresis, Mass spectroscopy, and Flow cytometry)

By Application
o Infectious Diseases
o Oncology
o Genetic Testing
o Blood Screening
o Others (Microbiology, Neurological Diseases, and Cardiovascular Diseases)

By End Users
o Hospitals
o Laboratories
o Others (Blood Banks, Home Health Agencies, and Nursing Homes)

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.